News
-
-
-
PRESS RELEASE
Formycon and Zydus: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by FDA
Formycon and Zydus announce FDA review of FYB206, first publicly announced Keytruda biosimilar filing, marking regulatory milestone under licensing agreement with Zydus. Could accelerate access to cancer therapy for patients -
-
-
-
-
-
-